The CMS selected dialysis providers DaVita and Fresenius Medical Care North America to participate in a pay-for-performance program for end-stage renal disease. The program is meant to test whether disease-management models can "effectively and efficiently" boost quality of care for such patients, the CMS said. The agency said it would reserve 5% of capitation payments to reward participating organizations for improving on past performance and performing better than the national averages for dialysis-related quality measures. The Medicare Advantage program will be offered in four states beginning Jan. 1, 2006. Fresenius will partner with Sterling Life Insurance Co. in Pennsylvania and Texas and with American Progressive Life and Health Insurance Co. in Massachusetts. DaVita will partner with SCAN Health Plan in California. -- by Matthew DoBias
CMS names participants for renal-disease program
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.